Table 2.
Patient Characteristics
| Characteristic | No. |
|---|---|
| Number of Patients | 29 |
| Age, Median (range) | 53 y (30–91 y) |
| Primary Disease Stage at Diagnosis | |
| I | 1 |
| II | 5 |
| III | 0 |
| IV | 21 |
| Unknown | 2 |
| Histopathologic Findings at Diagnosis | |
| T status | |
| 1 | |
| 2 | 11 |
| 3 | 6 |
| 4 | 7 |
| Unknown | 3 |
| N status | |
| Positive | 26 |
| Negative | 2 |
| Unknown | 1 |
| Tumor grade | |
| 1 | 1 |
| 2 | 13 |
| 3 | 15 |
| Estrogen receptor status | |
| Positive | 24 |
| Negative | 5 |
| Progesterone receptor status | |
| Positive | 13 |
| Negative | 16 |
| HER2/neu status | |
| Positive | 8 |
| Negative | 21 |
| Type of surgery | |
| Mastectomy | 5 |
| Breast-conserving therapy | 3 |
| No surgery | 21 |
| Bone metastatic site | |
| Spine | 26 |
| Pelvis | 18 |
| Rib | 10 |
| Type of treatment | |
| Standard chemotherapy | 20 |
| Hormone therapy | 9 |
| Availability of images | |
| At 3 mo after treatment initiation | |
| XR images | 24 |
| SS images | 18 |
| CT images | 24 |
| At 6 mo after treatment initiation | |
| XR images | 26 |
| SS images | 23 |
| CT images | 26 |